FILE NAME: Eternit (ETER) DATE: 1998 Nov 17 DOC#: ETER043 DOCUMENT DESCRIPTION: Letter to Alan Dalton, National Health & Safety Council from Reg Green, Health, Safety and Environment Officer RE Fernanda Giannasi 17.
refid# b52yV5K2rRNaMwZKe6ap8vMDO3 pages
FILE NAME: Hampshire (HAMP) DATE: 1994 Mar DOC#: HAMP111 DOCUMENT DESCRIPTION: Legal - Hampshire's Supplemental Answers to Interrogatories * b AyAMop -fo ^U o^j INTERROGATORE EQ.x_.161; SJnti 3f a State your understanding of vhat legal duties or obligations you have or had concerning testing, inspection, design, manufacturing and use of the asbestos-containing products identified in your Answers to interrogatory Nos. 8 and 19 before and after marketing them for sale.
refid# 4aLV15mj3Qo9KogneqeZx7qvN3 pages
FILE NAME: ALCOA (ALC) DATE: 1998 Feb 28 DOC#: ALC028 DOCUMENT DESCRIPTION: Legal-Deposition of Thomas Bonney with BC Notes *2 ^ 7 ^ 7 /k & ^ S f S f - S f S Z Ss - d d S S S t^ b S S f S?
refid# x1MJbmqM0XDaOkGYLOXoZgr8683 pages
BOARD BOARD OF OF DIRECTORS DIRECTORS PPRREF~SEENNTTAATTIIOONNS$ NNOOVVEEMMBBEERR 9, 9, 1998 1998 August, 1998 FCISSUES 11552277..00000011 wo So3MA10081840 cBckoduchee eles ES LWchqetebee _ TS Ddoust on fotoCelechs of, chomcals -kcycle i.
refid# 0L6bngxJdm5ZN6dwmpOGJKDLk52 pages
ACTIVATED SLUDGE RESPIRATION INHIBITION TEST EEX TESTSUBSTANCE -- _-- - Identity: PFCe-r8f5l.uor(o1o-cOtacnteasnuelsfuolnfaotnei;c macaidy,a1l,s1o,2b.e2.r3e,f3e.r4r,e4d.5t,o5,a6s.6P.7F.O7.S8.o8r.8heptadecafluoro-, potassium salt, CAS # 2795-39-3) Remarks: from 3M lot nuTmhbeetres2t17s.ubsStaamnpcleeiswaaswhsittoerepdowudnedre.r Sample ambient was taken condifions, pNrMioRr taontdesteilnegm.enPturailtyandaeltyesremsinteedchtnoiqbuees9.0.49% by LC/MS, 'H-HMR, '*F- METHOD a EE Method: OECD 203 Test type: Stalic acute GYeLaPr: CYoemspleted: Study completed 1999.
refid# pmZ7vGmE2JrKy1bLqeJRY75jB3 pages
AR226- 0o4H ACUTE TOXICITY TO THE SALTWATER MYSID LE-F TESTSUBSTANCE Identity: PFeCr-f9lu5o.ro(o1c-tOacnteasnuelsounlaftoen;icmaaciyd,al1s,o1,b2e.2r.e3f,e3r,r4e,d4,t5o,5a,s6,P6,F7O,7S.8o.r8.8heptadecafluoro-, potassium salt, CAS # 2795.35-3) fRreommar3kMsl:ot nuTmhbeetres2t17s.ubsStaamnpcleeiws aaswhsittoerepdowudnedre.r Sample ambient was taken conditions pNrMioRr taontdesetilnegm.enPturailtyandaeltyesremsinteedchtnoiqbuees9.0.49% by LC/MS, 'H-HMR, 'F- METHOD Method: OPPTS 850.1035 Type: Static acute GLP: Yes YSpeeacriecosm:pMlyestieddo:psSitsudbyahcioampleted 1999.
refid# YrQGX43EeevVr6mQ8Xy96aEb84 pages
WW SAAaSSHHIaINNGeGST aOTsONS MUTAGENICITY TEST ON ns IN AN I VIVO RAT MICRONICLEUS ASSAY Dama sEouIERUENT 5.5.
refid# QXK4NDkNXGd5MyYv1JxjKqB4k41 pages
TN Ags 3M gene | Foo 3CMopMeedicTa DepgartmenY t P S AR 226- 0950 = iNAY 2 0F00- 373 ~ = aFnludoFriolcmhePmliacnatlEEmxpploosyuerees(Serum) Assessment of Decatur Chemical E Historically, employees a the 3M Decatur chemical plant have voluntarily participated in & biennial fluorochemical medical surveillance program: Total organic fluorine was measured until 1994 when perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) were assayed.
refid# kYY9D8N6rKgYpq9gwy4x801B394 pages
SPONSOR ElfAtochemS.A.
refid# N2G6Eo6OEKdQQ1ma1wo0VM0aQ29 pages
AR226-3039 Study Title Approximate Lethal Dose (ALD) of H-21460 in Rats Laboratory Project ID HaskeH Laboratory Report No. 176-96 Author Tracy A.
refid# n9oakrvb8ev0ox0pQ45M1E9XR7 pages
AR226-3075 Study Title Inhalation Toxicity Screen wit Laboratory Project IP HL-1997-00600 Author David P.
refid# OEM0L9nZ6xM18Kao2JZBQy9zX2 pages
ACTIVATED SLUDGE RESPIRATION INHIBITION TEST TEST SUBSTANCE Identity:N-Ethylperfluorooctanesulfonamidmea;y alsobe referredtoas U1464, ETFOSA, ETPOSA, F-6309,or FX-12. (1Octanesulfonamide,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-N-ethylC-A,S # 4151-50-2) Remarks: Materialisa whitesolid.Sample purityand lotnumber were not recorded.
refid# ZBZNy8EqNa4onVwdyQJqqnREV9 pages
MICROBICS MICROTOX@ TOXICITY TEST TEST SUBSTANCE Identity:Mixturecontainingperfluorooctanesulfonawtheich may alsobe referredto as PFOS, FC-95, or as a component ofFC-3003. (1Octanesulfoniaccid)(CAS # 2795-39-3).
refid# RpOawk7reNjKoxgJkL9KBx5QV9 pages
MAGYOSZ'S DETAILED POSITION STATEMENT ON THE EUROPEAN USE OF "PER- AND POLYFLUOROALKYL SUBSTANCES" (PFAS),1 CONSIDERING THE RESTRICTION PROPOSAL SET FORTH IN THE REACH2 REGULATION BACKGROUND AND BASELINE CONSIDERATIONS Founded in 1990 to represent the Hungarian pharmaceutical industry, the Hungarian Pharmaceutical Manufacturers' Association (MAGYOSZ) has been operating in strategic partnership with the Ministry of Foreign Affairs and Trade, and thus indirectly with the Government of Hungary, since 2020.
refid# Raamq2RZQkn53J2p25RJr2ad77 pages
INTER-COMPANY MEMO KkochINDUSTRIES INC PLAINTIFF'S EXHIBIT KRC-49 CjT A?
refid# 2NKRbbYkGzaap5OywODMJJBQN1 page